Maraviroc

名称和标识

IUPAC标准名

4,4-difluoro-N-[(1S)-3-[(1R,3S,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide

IUPAC传统名

4,4-difluoro-N-[(1S)-3-[(1R,3S,5S)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide

别名

4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamideUK-427857Maraviroc

数据登录号

CAS号

376348-65-1

MDL号

MFCD13188530

化合物性质

理化性质

外观

white powder

比旋光度

[α]-15/D

溶解度

DMSO: >30 mg/mL

安全信息

安全公开号

22-36

欧盟危险性物质标志

有害性 (Xn)

德国WGK号

危险公开号

48/22

MSDS下载

下载链接

保存温度

room temp

产品相关信息

纯度

≥98% (HPLC)

Empirical Formula (Hill Notation)

C29H41F2N5O

描述信息

Legal Information
Sold for research purposes under agreement from Pfizer Inc.
Biochem/physiol Actions
Maraviroc is a CCR5 chemokine receptor antagonist, and antiretroviral entry inhibitor. Maraviroc inhibits HIV entry by blocking interaction of viral coat protein gp120 with the receptor.

分子图谱

暂无数据

点击上传数据

参考文献